AUPH Q1 2017 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$31,000-45.6% YoY

Gross Profit

$30,00096.8% margin

Operating Income

-$11M-35758.1% margin

Net Income

-$52M-167551.6% margin

EPS (Diluted)

$-0.92

QoQ Revenue Growth

+3.3%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$220M

Total Liabilities

$47M

Stockholders' Equity

$173M

Cash & Equivalents

$199M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31,000	$57,000	-45.6%
Gross Profit	$30,000	$56,000	-46.4%
Operating Income	-$11M	-$5M	-128.7%
Net Income	-$52M	-$4M	-1117.3%